Parathyroid Diseases Withdrawn Phase 3 Trials for Sodium chloride (DB09153)

Also known as: Parathyroid Disease

IndicationStatusPhase
DBCOND0036113 (Parathyroid Diseases)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs